Laser Photonics Q3 net sales rise 25%, net loss narrows

By Reuters News


Overview

  • US laser technology firm's Q3 net sales grew 25%, first quarter of yr/yr growth since Q4 2025

  • Q3 net loss narrowed 46%, driven by lower operating and interest expenses

  • Company raised $7.9 mln in September equity offering, eliminated $4.6 mln in notes payable


Outlook

  • Company plans to introduce Quantum Bullet anti-drone platform at I/ITSEC in late November 2026

  • LASE expects to continue serving pharmaceutical, semiconductor and industrial markets while prioritizing defense opportunities

  • Company is not providing quantitative financial guidance at this time


Result Drivers

  • OPERATING EXPENSE REDUCTION - Q3 operating expenses fell 34%, mainly due to lower general and administrative costs

  • INTEREST EXPENSE REDUCTION - Lower interest expense contributed to improved net loss

  • GROWTH STRATEGY FOCUS - Co clarified strategy around directed-energy technologies for defense, semiconductor, pharmaceutical and industrial markets


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

$1.1 mln


Reuters Recommended Reads

  • Nov 10 - Velo3D's Q3 revenue rises 50%, beats estimates

  • Nov 10 - Evolv Technologies Q3 net loss widens on large contract absence

  • Nov 9 - Quantum Computing Q3 swings to net loss on higher operating expenses, acquisitions


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk